Table 1.
Clinicopathological features of samples
| Characteristic | Status | Number of patients (%) |
|---|---|---|
| Stage | I | 8 (16) |
| II | 15 (30) | |
| III | 12 (24) | |
| IV | 9 (18) | |
| Unknown | 6 (12) | |
| Age | <45 | 20 (40) |
| >45 | 24 (48) | |
| Unknown | 6 (12) | |
| Lymph node metastasis | Yes | 17 (34) |
| No | 26 (52) | |
| Unknown | 7 (14) | |
| Tumor size (TS) | <2 cm | 15 (30) |
| 5>TS>2 | 5 (10) | |
| >5 cm | 29 (58) | |
| Unknown | 1 (2) | |
| Menopausal status | Yes | 12 (24) |
| No | 15 (30) | |
| Unknown | 23 (46) | |
| ER receptor | Positive | 14 (28) |
| Negative | 13 (26%) | |
| Unknown | 23 (46%) | |
| PR receptor | Positive | 19 (38%) |
| Negative | 21 (42%) | |
| Unknown | 10 (20%) | |
| HER2/neu receptor | Positive | 12 (24%) |
| Negative | 21 (42%) | |
| Unknown | 17 (34%) |
ER, PR: Estrogen receptor, Progesterone receptor